Anogenital cancers testing in Casalfiumanese

Find health labs to test for Anogenital cancers in Casalfiumanese and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Via Turibio Baruzzi, 7 40026 Imola (BO)

6.2 km

Unverified

See Details

Pap Smear by Synlab

Via Firenze, 15, 48025 Riolo Terme RA, Italia

5.6 km

Unverified

See Details

Pap Smear by Synlab

Via Cogne, 4, 40026 Imola BO, Italia

6.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Marcello Malpighi, 126 48018 Faenza (RA)

13.2 km

Unverified

See Details

Pap Smear by Synlab

Via Casenuove, 44, 48018 Faenza RA, Italia

13.2 km

Unverified

See Details

Pap Smear by Synlab

Via Martiri della Libertà, 14, 48024 Massa Lombarda RA, Italia

14.7 km

Unverified

See Details

Pap Smear by Synlab

Piazza Gastone Piccinini, 3, 40067 Pianoro BO, Italia

14.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Mazzini, 150/2F 40138 Bologna (BO)

19.2 km

Unverified

See Details

Pap Smear by Synlab

Via Selice, 121, 48017 Conselice RA, Italia

18.2 km

Unverified

See Details

Pap Smear by Synlab

Via Lagarete, 6, 40048 San Benedetto Val di Sambro BO, Italia

19.8 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.